Furthermore, it has been shown that PCA has significantly increased RNF2 expression and that RNF2 inhibition can increase TXNIP expression by binding to the TXNIP promoter, which may result in PCA cell-cycle arrest, enhancing apoptosis and preventing tumor progression [72]. The gene discussed is TXNIP; the disease is posterior cortical atrophy.